Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
There is a choice for immunosuppressive drug nephrotoxicity: is it time to change
Journal of Nephrology, 07/02/09
Stallone G et al. - The central issue in organ transplantation remains suppression of allograft rejection. Thus, development of immunosuppressive drugs is the key to successful allograft function. To obtain significant long-term improvement in renal allograft outcomes, it may be necessary to adopt new immunosuppressive regimens that rely less on CNIs.
Related Articles
Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors
European Journal of Cancer, 10/23/09
Relevance Score: 85%%
What I tell my patients about contrast medium nephrotoxicity
British Journal of Renal Medicine, 10/27/09
Relevance Score: 82%%
Long-Term Evaluation of Ifosfamide-Related Nephrotoxicity in Children
Journal of Clinical Oncology, 10/26/09
Relevance Score: 82%%
Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells
American Journal of Physiology: Renal Physiology, 11/12/09
Relevance Score: 80%%
Renal Dendritic Cells Ameliorate Nephrotoxic Acute Kidney Injury
Journal of the American Society of Nephrology, 11/04/09
Relevance Score: 80%%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Azelastine nasal spray for the treatment of allergic and nonallergic rhinitis
Expert Review of Clinical Immunology, 11/23/09
Update in treatment options for psoriatic arthritis
Expert Review of Clinical Immunology, 11/23/09
Induction With and Without Antithymocyte Globulin Combined With Cyclosporine/Tacrolimus-Based Immunosuppression in Renal Transplantation: A Meta-analysis of Randomized Controlled Trials
Transplantation Proceedings, 11/23/09
Today in Nephrology/Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Induction With and Without Antithymocyte Globulin Combined With Cyclosporine/Tacrolimus-Based Immunosuppression in Renal Transplantation: A Meta-analysis of Randomized Controlled Trials
Transplantation Proceedings, 11/23/09
Phase I Clinical Trial of an Adenovirus/Prostate-Specific Antigen Vaccine for Prostate Cancer: Safety and Immunologic Results
Clinical Cancer Research, 11/20/09
Long-Term Experience of Plasmapheresis in Antibody-Mediated Rejection in Renal Transplantation
Transplantation Proceedings, 11/20/09
Today in Surgery/Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Factors affecting neutrophil recovery after autologous bone marrow-derived stem cell transplantation in patients with acute myeloid leukemia
Transplantation Proceedings, 11/23/09
Antiretroviral and Immunosuppressive Drug-Drug Interactions in Human Immunodeficiency Virus-Infected Liver and Kidney Transplant Recipients
Transplantation Proceedings, 11/23/09
Induction With and Without Antithymocyte Globulin Combined With Cyclosporine/Tacrolimus-Based Immunosuppression in Renal Transplantation: A Meta-analysis of Randomized Controlled Trials
Transplantation Proceedings, 11/23/09
Sponsor
Article Search
Sponsor


See Latest Articles


